🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Superb experience presenting my research on outcomes after kidney transplant in patients with chronic liver disease. Very well organized conference with great lectures in beautiful Vail, CO. Highly recommend applying for YIF! Thank you CU Transplant Center for the opportunity.

📷 Exciting Announcement 📷 As the new Internal Medicine Chief Residents, we want to express our heartfelt gratitude to the outgoing Chiefs for their exceptional tenure and leadership.

“Update on Clinical Trials for Nonalcoholic Steatohepatitis” by Rohit R. Nathani, MD, and Meena B. Bansal, MD buff.ly/43I6V4L Rohit Nathani Meena Bansal Mount Sinai Morningside Icahn School of Medicine at Mount Sinai

Universal alcohol biomarker monitoring improves drinking detection & accountability during evaluation for #liver #transplantation by @adam_c_winters Gene Im @ronathanimd @chipsbowman et al journals.lww.com/lt/citation/99… #livertwitter #livertransplant #alcoholuse

Wonderful to meet Hanna Blaney, MD, MPH in person, future ⭐️ in alcohol-associated liver dz. 😲 to see our posters were complementary to examine the impact of hepatology consultation in inpt addiction units & FibroScan to ⬆️ motivation to improve abstinence Stephanie Rutledge Rohit Nathani

Hot off the press: adding AGE to MELD or ACLF grade improves survival prediction in Alc Hep Hepatology Communications by Stephanie Rutledge & Rohit Nathani AGE helps explain ↑ waitlist survival in AH v MASLD or AC AGE>45 or MELD >35 = ↑90 d mortality from WL decision shorturl.at/Bb9Zx